Company profile · Biotech & medical
Pharmosa Biopharm
國邑藥品科技股份有限公司 · 6875
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Pharmosa Biopharm is a drug delivery system company focusing on combining drugs and devices.[1]
The company engages in new drug research and development involving novel drug-device delivery systems.[2]
Pharmosa Biopharm develops sustained release inhaled treprostinil (L606).[1]
The company commercializes its products through 505(b)2 or hybrid applications to regulatory authorities with regional and global strategic partnerships.[3]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$2m | – | -65.3% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | −NT$3m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | Pharmosa Biopharm Inc. |
|---|---|
| Chinese name | 國邑藥品科技股份有限公司 |
| Stock code | 6875 (TPEx) |
| Industry | Biotech & medical |
| Founded | 25 May 2000 |
| Listed | 26 Mar 2024 |
| Paid-in capital | NT$646m |
| Chairman | 王建治 |
| President | 甘霈 |
| Headquarters | 11F, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City 11511, Taiwan (R.O.C.) |
| Website | https://www.pharmosa.com.tw |
| Official business description | 新藥研發(新型藥械投藥系統) |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- Pharmosa Biopharm | Pharmosa Biopharm · website · retrieved 04 Nov 2026
- MOPS 公司基本資料 國邑藥品科技股份有限公司 · mops · retrieved 04 Nov 2026
- Company Profile | Pharmosa Biopharm · website · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list